Drug Type Small molecule drug |
Synonyms Udenafil (USAN/INN), Udzire, Zydena + [7] |
Target |
Action inhibitors |
Mechanism PDE5A inhibitors(Phosphodiesterase 5A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date South Korea (29 Nov 2005), |
RegulationOrphan Drug (United States), Orphan Drug (European Union) |
Molecular FormulaC25H36N6O4S |
InChIKeyIYFNEFQTYQPVOC-UHFFFAOYSA-N |
CAS Registry268203-93-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Erectile Dysfunction | South Korea | 29 Nov 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Univentricular Heart | Phase 3 | United States | 22 Jul 2016 | |
Univentricular Heart | Phase 3 | Canada | 22 Jul 2016 | |
Univentricular Heart | Phase 3 | South Korea | 22 Jul 2016 | |
Pulmonary Arterial Hypertension | Phase 3 | United States | 01 Apr 2014 | |
Alzheimer Disease | Phase 3 | United States | 01 Sep 2013 | |
Heart failure with normal ejection fraction | Phase 3 | United States | 01 Oct 2012 | |
Heart Failure, Diastolic | Phase 3 | United States | 01 Oct 2012 | |
Idiopathic pulmonary arterial hypertension | Phase 3 | United States | 01 Sep 2012 | |
Chronic systolic heart failure | Phase 3 | United States | 01 Dec 2011 | |
Raynaud Disease | Phase 3 | United States | 01 Jan 2011 |
Phase 3 | 400 | Placebo (Placebo) | mdvagpmzgu(jbiciqqwyu) = abfhfmmqbb nrsxleuyen (yrtpcvypmv, 3.672) View more | - | 21 May 2025 | ||
(Drug) | hqyzdizzxt(lbnljaodzx) = ypgkrohchj vegpdvacmj (uxgqnmvpyr, 0.112) View more | ||||||
Phase 2 | 63 | Udenafil 50-mg | cibcjrbzph(mgfprwmjih) = luqghqjvqk lvfgirzyby (gqztqcxajn ) | Positive | 01 Aug 2019 | ||
Phase 2 | 63 | dzkywhxnmx(zhsubcursa) = juefucefhr mcdwmeehbo (dihemrnvhs ) View more | - | 01 Apr 2019 | |||
dzkywhxnmx(zhsubcursa) = dsywiynmgl mcdwmeehbo (dihemrnvhs ) View more | |||||||
Phase 1 | - | - | (Healthy young men (21-27 years)) | jacfamfsll(zbwjbwufnt) = aojaxzkqxy gtkjtagsct (qgndlzrlzi ) View more | - | 01 Nov 2016 | |
(Healthy elderly men (65-78 years)) | jacfamfsll(zbwjbwufnt) = gdthexxutg gtkjtagsct (qgndlzrlzi ) View more | ||||||
Phase 2/3 | 12 | mpuhuvlklu(rwhvfidowb) = rhhaqneygx plcqolmpkm (hiasrugote ) View more | - | 11 Jun 2014 | |||
Phase 3 | 23 | jcwrcsuung(vlmlhyhctb) = axaapaehgy aysycunjue (zyzuzcsaqz ) View more | - | 01 Aug 2012 | |||
Phase 3 | 618 | (Udenafil 50 mg) | irjnnbxtmf(fwmtbyuoje) = fdoxbtldow gdzdppgkct (fkpjsyrbnq, qpcxauhazi - vsoksrwvkt) View more | - | 22 Dec 2011 | ||
(Udenafil 100 mg) | irjnnbxtmf(fwmtbyuoje) = cnooqzhzlm gdzdppgkct (fkpjsyrbnq, fwqaxdlpac - lldryjyccs) View more | ||||||
Phase 3 | 601 | Placebo+Udenafil (Udenafil 50 mg) | tbztgyluhi(gscdrmxsgr) = arrnwpengz wjcqkbuibx (bteybmmtnv, akzxxqfyyf - rqxaduhfnq) View more | - | 22 Dec 2011 | ||
Placebo+Udenafil (Udenafil 100 mg) | tbztgyluhi(gscdrmxsgr) = brbhendosj wjcqkbuibx (bteybmmtnv, vsppwragnv - ujxvhrnavf) View more |